Prognostic Impact of Albumin-bilirubin Score on the Prediction of In-hospital Mortality in Patients with Heart Failure: a Retrospective Cohort Study

Overview

Journal BMJ Open

Specialty General Medicine

Date 2022 Jan 5

PMID 34983753

Citations 9

Authors

Su Han

Chuanhe Wang

Fei Tong

Ying Li

Zhichao Li

Zhaoqing Sun

Zhijun Sun

Affiliations

Soon will be listed here.

Abstract

Objectives: Liver dysfunction is prevalent in patients with heart failure (HF) and can lead to poor prognosis. The albumin-bilirubin (ALBI) score is considered as an effective and convenient scoring system for assessing liver function. We analysed the correlation between ALBI and in-hospital mortality in patients with HF.

Design: A retrospective cohort study.

Setting And Participants: A total of 9749 patients with HF (from January 2013 to December 2018) was enrolled and retrospectively analysed.

Main Outcome Measures: The main outcome is in-hospital mortality.

Results: ALBI score was calculated using the formula (log bilirubin [umol/L] * 0.66) + (albumin [g/L] * -0.085), and analysed as a continuous variable as well as according to three categories. Following adjustment for multivariate analysis, patients which occurred in-hospital death was remarkably elevated in tertile 3 group (ALBI ≥2.27) (OR 1.671, 95% CI 1.228 to 2.274, p=0.001), relative to the other two groups (tertile 1: ≤2.59; tertile 2: -2.59 to -2.27). Considering ALBI score as a continuous variable, the in-hospital mortality among patients with HF increased by 8.2% for every 0.1-point increase in ALBI score (OR 1.082; 95% CI 1.052 to 1.114; p<0.001). The ALBI score for predicting in-hospital mortality under C-statistic was 0.650 (95% CI 0.641 to 0.660, p<0.001) and the cut-off value of ALBI score was -2.32 with a specificity of 0.630 and a sensitivity of 0.632. Moreover, ALBI score can enhance the predictive potential of NT-pro-BNP (NT-pro-BNP +ALBI vs NT-pro-BNP: C-statistic: z=1.990, p=0.0467; net reclassification improvement=0.4012, p<0.001; integrated discrimination improvement=0.0082, p<0.001).

Conclusions: In patients with HF, the ALBI score was an independent prognosticator of in-hospital mortality. The predictive significance of NT-proBNP +ALBI score was superior to NT-proBNP, and ALBI score can enhance the predictive potential of NT-proBNP.

Citing Articles

The Prognostic Value of Platelet-Albumin-Bilirubin Score in Patients Undergoing Transcatheter Aortic Valve Replacement.

Duan X, Qu L, Chen H Clin Cardiol. 2025; 48(3):e70100.

PMID: 39992725 PMC: 11849681. DOI: 10.1002/clc.70100.

Association Between the Albumin-Bilirubin (ALBI) Score and All-cause Mortality Risk in Intensive Care Unit Patients with Heart Failure.

Wang J, Wang K, Feng G, Tian X Glob Heart. 2024; 19(1):97.

PMID: 39713194 PMC: 11661052. DOI: 10.5334/gh.1379.

Prognostic value of albumin-based indices for mortality after heart failure: a systematic review and meta-analysis.

Jiang J, Miao P, Xin G BMC Cardiovasc Disord. 2024; 24(1):570.

PMID: 39420315 PMC: 11484320. DOI: 10.1186/s12872-024-04244-9.

Association between albumin-bilirubin score and in-hospital mortality in patients with sepsis: Evidence from two large databases.

Gou E, Yang Q, Chen J, Kong T, Tang Z, Wen Q Heliyon. 2024; 10(15):e34697.

PMID: 39170393 PMC: 11336323. DOI: 10.1016/j.heliyon.2024.e34697.

Association of easy albumin-bilirubin score with increased mortality in adult trauma patients.

Hsu S, Rau C, Tsai C, Chou S, Su W, Hsieh C Front Surg. 2024; 11:1280617.

PMID: 38721021 PMC: 11076689. DOI: 10.3389/fsurg.2024.1280617.

References

Lei Q, Zhang Y, Ke C, Yan C, Huang P, Shen H . Value of the albumin-bilirubin score in the evaluation of hepatitis B virus-related acute-on-chronic liver failure, liver cirrhosis, and hepatocellular carcinoma. Exp Ther Med. 2018; 15(3):3074-3079. PMC: 5795478. DOI: 10.3892/etm.2018.5748. View

Harjola V, Mullens W, Banaszewski M, Bauersachs J, Brunner-La Rocca H, Chioncel O . Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2017; 19(7):821-836. PMC: 5734941. DOI: 10.1002/ejhf.872. View

Alvarez A, Mukherjee D . Liver abnormalities in cardiac diseases and heart failure. Int J Angiol. 2012; 20(3):135-42. PMC: 3331650. DOI: 10.1055/s-0031-1284434. View

Johnson P, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves H . Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2014; 33(6):550-8. PMC: 4322258. DOI: 10.1200/JCO.2014.57.9151. View

Grodin J, Gallup D, Anstrom K, Felker G, Chen H, Tang W . Implications of Alternative Hepatorenal Prognostic Scoring Systems in Acute Heart Failure (from DOSE-AHF and ROSE-AHF). Am J Cardiol. 2017; 119(12):2003-2009. PMC: 5477997. DOI: 10.1016/j.amjcard.2017.03.031. View

Laribi S, Mebazaa A . Cardiohepatic syndrome: liver injury in decompensated heart failure. Curr Heart Fail Rep. 2014; 11(3):236-40. DOI: 10.1007/s11897-014-0206-8. View

Kim M, Kato T, Farr M, Wu C, Givens R, Collado E . Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction. J Am Coll Cardiol. 2013; 61(22):2253-2261. PMC: 3939720. DOI: 10.1016/j.jacc.2012.12.056. View

DeLong E, Delong D, Clarke-Pearson D . Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44(3):837-45. View

Giallourakis C, Rosenberg P, Friedman L . The liver in heart failure. Clin Liver Dis. 2003; 6(4):947-67, viii-ix. DOI: 10.1016/s1089-3261(02)00056-9. View

10.

Inohara T, Kohsaka S, Shiraishi Y, Goda A, Sawano M, Yagawa M . Prognostic impact of renal and hepatic dysfunction based on the MELD-XI score in patients with acute heart failure. Int J Cardiol. 2014; 176(3):571-3. DOI: 10.1016/j.ijcard.2014.08.052. View

11.

Biegus J, Zymlinski R, Sokolski M, Siwolowski P, Gajewski P, Nawrocka-Millward S . Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure. Eur J Heart Fail. 2016; 18(12):1518-1521. DOI: 10.1002/ejhf.644. View

12.

Hiraoka A, Kumada T, Kudo M, Hirooka M, Tsuji K, Itobayashi E . Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications. Liver Cancer. 2017; 6(3):204-215. PMC: 5473065. DOI: 10.1159/000452846. View

13.

Artunc F, Mueller C, Breidthardt T, Twerenbold R, Rettig I, Usta E . Comparison of the diagnostic performance of three natriuretic peptides in hemodialysis patients: which is the appropriate biomarker?. Kidney Blood Press Res. 2012; 36(1):172-81. DOI: 10.1159/000343406. View

14.

Aimo A, Januzzi Jr J, Mueller C, Miro O, Pascual Figal D, Jacob J . Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure. Int J Cardiol. 2019; 293:137-142. DOI: 10.1016/j.ijcard.2019.06.005. View

15.

Hiraoka A, Kumada T, Michitaka K, Kudo M . Newly Proposed ALBI Grade and ALBI-T Score as Tools for Assessment of Hepatic Function and Prognosis in Hepatocellular Carcinoma Patients. Liver Cancer. 2019; 8(5):312-325. PMC: 6873026. DOI: 10.1159/000494844. View

16.

Shao L, Han B, An S, Ma J, Guo X, Romeiro F . Albumin-to-bilirubin score for assessing the in-hospital death in cirrhosis. Transl Gastroenterol Hepatol. 2017; 2:88. PMC: 5723748. DOI: 10.21037/tgh.2017.09.11. View

17.

Zoair A, Abdel-Hafez M, Mawlana W, Sweylam M . Serum levels of N-terminal-pro B-type natriuretic peptide as a diagnostic marker for left ventricular dysfunction in children with end-stage renal disease on hemodialysis. Saudi J Kidney Dis Transpl. 2016; 27(6):1114-1122. DOI: 10.4103/1319-2442.194593. View

18.

Peng J, Xiao X, Hu M, Zhang X . Interaction between gut microbiome and cardiovascular disease. Life Sci. 2018; 214:153-157. DOI: 10.1016/j.lfs.2018.10.063. View

19.

Pencina M, DAgostino Sr R, DAgostino Jr R, Vasan R . Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2007; 27(2):157-72. DOI: 10.1002/sim.2929. View

20.

Kato T, Niizuma S, Inuzuka Y, Kawashima T, Okuda J, Kawamoto A . Analysis of liver metabolism in a rat model of heart failure. Int J Cardiol. 2011; 161(3):130-6. DOI: 10.1016/j.ijcard.2011.07.056. View